BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9751427)

  • 21. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine--folate, a potential radiopharmaceutical for tumor imaging.
    Wang S; Lee RJ; Mathias CJ; Green MA; Low PS
    Bioconjug Chem; 1996; 7(1):56-62. PubMed ID: 8741991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of a (68)Ga labeled folic acid derivative for targeting folate receptors.
    Jain A; Mathur A; Pandey U; Bhatt J; Mukherjee A; Ram R; Sarma HD; Dash A
    Appl Radiat Isot; 2016 Oct; 116():77-84. PubMed ID: 27501138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging of atherosclerosis in apoliprotein e knockout mice: targeting of a folate-conjugated radiopharmaceutical to activated macrophages.
    Ayala-López W; Xia W; Varghese B; Low PS
    J Nucl Med; 2010 May; 51(5):768-74. PubMed ID: 20395331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation and tumor cell uptake of poly(N-isopropylacrylamide) folate conjugates.
    Dubé D; Francis M; Leroux JC; Winnik FM
    Bioconjug Chem; 2002; 13(3):685-92. PubMed ID: 12009963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biotin derivatives of folate compounds: synthesis and utilization for visualization and affinity purification of folate transport proteins.
    Fan J; Huennekens FM
    Methods Enzymol; 1997; 281():97-105. PubMed ID: 9250972
    [No Abstract]   [Full Text] [Related]  

  • 26. Synthesis and grafting of thioctic acid-PEG-folate conjugates onto Au nanoparticles for selective targeting of folate receptor-positive tumor cells.
    Dixit V; Van den Bossche J; Sherman DM; Thompson DH; Andres RP
    Bioconjug Chem; 2006; 17(3):603-9. PubMed ID: 16704197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation.
    Bakker WH; Albert R; Bruns C; Breeman WA; Hofland LJ; Marbach P; Pless J; Pralet D; Stolz B; Koper JW
    Life Sci; 1991; 49(22):1583-91. PubMed ID: 1658515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting.
    Müller C; Hohn A; Schubiger PA; Schibli R
    Eur J Nucl Med Mol Imaging; 2006 Sep; 33(9):1007-16. PubMed ID: 16763819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery.
    Paulos CM; Reddy JA; Leamon CP; Turk MJ; Low PS
    Mol Pharmacol; 2004 Dec; 66(6):1406-14. PubMed ID: 15371560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitration and chlorination of folic acid by peroxynitrite and hypochlorous acid, and the selective binding of 10-nitro-folate to folate receptor beta.
    Nakamura M; Nagayoshi R; Ijiri K; Nakashima-Matsushita N; Takeuchi T; Matsuyama T
    Biochem Biophys Res Commun; 2002 Oct; 297(5):1238-44. PubMed ID: 12372420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a reduced folate/methotrexate carrier in human KB-cells expressing high levels of membrane associated folate binding protein.
    Westerhof GR; Schornagel JH; Rijnboutt S; Pinedo HM; Jansen G
    Adv Exp Med Biol; 1993; 338():771-4. PubMed ID: 8304226
    [No Abstract]   [Full Text] [Related]  

  • 32.
    Liang L; Zhang X; Su X; Li J; Tian Y; Xue H; Xu H
    J Labelled Comp Radiopharm; 2018 Feb; 61(2):54-60. PubMed ID: 29086447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors.
    Bettio A; Honer M; Müller C; Brühlmeier M; Müller U; Schibli R; Groehn V; Schubiger AP; Ametamey SM
    J Nucl Med; 2006 Jul; 47(7):1153-60. PubMed ID: 16818950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folate-PEG-NOTA-Al
    Chen Q; Meng X; McQuade P; Rubins D; Lin SA; Zeng Z; Haley H; Miller P; González Trotter D; Low PS
    Mol Pharm; 2017 Dec; 14(12):4353-4361. PubMed ID: 29028357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting dendrimer-chelates to tumors and tumor cells expressing the high-affinity folate receptor.
    Wiener EC; Konda S; Shadron A; Brechbiel M; Gansow O
    Invest Radiol; 1997 Dec; 32(12):748-54. PubMed ID: 9406015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of specific SPECT-radiopharmaceutical for tumor imaging based on methionine: 99mTc-DTPA-bis(methionine).
    Hazari PP; Shukla G; Goel V; Chuttani K; Kumar N; Sharma R; Mishra AK
    Bioconjug Chem; 2010 Feb; 21(2):229-39. PubMed ID: 20108938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Folate receptor and its application in the selective receptor-mediated targeting therapy of tumor cells--review].
    Gao XN; Tang SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):911-4. PubMed ID: 16277870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of the 111In-DTPA complex by the electromigration method.
    Ivanov PI; Bontchev GD; Bozhikov GA; Filossofov DV; Maslov OD; Milanov MV; Dmitriev SN
    Appl Radiat Isot; 2003 Jan; 58(1):1-4. PubMed ID: 12485655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folate-targeted therapies for cancer.
    Xia W; Low PS
    J Med Chem; 2010 Oct; 53(19):6811-24. PubMed ID: 20666486
    [No Abstract]   [Full Text] [Related]  

  • 40. Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulation.
    Liu G; Dou S; Rusckowski M; Greiner D; Hnatowich D
    Appl Radiat Isot; 2010 Sep; 68(9):1709-14. PubMed ID: 20359901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.